Evidence map›Paper›PMID 40411374›Full record

ArticleProtein science : a publication of the Protein Society2025

Functional implications of hexameric dynamics in SARS-CoV-2 Nsp15.

Manashi Sonowal, Gihan Ketawala, Nirupa Nagaratnam, Dhenugen Logeswaran, Shibom Basu, Daniele de Sanctis, Julien Orlans, Samuel L Rose, Rebecca J Jernigan, Hao Hu and 9 more

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Functional implications of hexameric dynamics in SARS-CoV-2 Nsp15.Protein science : a publication of the Protein Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Manashi SonowalCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-4665-8831
Gihan KetawalaCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-9436-3536
Nirupa NagaratnamCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-3201-930X
Dhenugen LogeswaranSchool of Molecular Sciences, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-3522-3883
Shibom BasuEuropean Molecular Biology Laboratory (EMBL), Grenoble, France.ORCID 0000-0001-6484-8236
Daniele de SanctisESRF, The European Synchrotron, Grenoble, France.ORCID 0000-0003-0391-8290
Julien OrlansESRF, The European Synchrotron, Grenoble, France.ORCID 0000-0002-6933-2287
Samuel L RoseESRF, The European Synchrotron, Grenoble, France.ORCID 0000-0003-4824-4066
Rebecca J JerniganCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-3586-3936
Hao HuCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0003-3472-0404
Jose Domingo Meza AguilarCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0009-0004-9412-0413
Madurangi E RanaweeraCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0001-6326-6226
Michele A ZacksCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0003-4277-7689
Julian J-L ChenSchool of Molecular Sciences, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-7253-2722
Debra T HansenCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0003-4395-8297
Lynn G SchragCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0002-7704-8841
Raimund FrommeCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0003-4835-1080
Sabine BothaCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0003-4362-7543
Petra FrommeCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0003-0953-4909

Funding

Biodesign Center for Applied Structural DiscoveryNational Science Foundation 1935994National Science Foundation 2031343National Science Foundation 2153503National Science Foundation STC-1231306
6 · The paper itself

Abstract

SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has undergone continuous evolution, leading to the emergence of variants with altered transmissibility and immune evasion. For the non-structural proteins (Nsps) of SARS-CoV-2, there are limited structural analyses of their naturally occurring mutations. Here, we identified four non-synonymous single-nucleotide polymorphisms (nsSNPs) in the Epsilon lineage of SARS-CoV-2 within Nsp15, an endoribonuclease critical for immune evasion. Of these Epsilon nsSNPs, E266Q is in the catalytic domain. This study investigates the effects of this on enzymatic activity, structural stability, and oligomeric assembly by serial crystallography. By solving the structure of the Nsp15 hexamer at room temperature of both Nsp15-E266Q and WT in the P2

Indexed as

EndoribonucleasesSARS-CoV-2Viral Nonstructural ProteinsCOVID-19Crystallography, X-RayHumansModels, MolecularPolymorphism, Single NucleotideProtein MultimerizationEndoribonucleasesViral Nonstructural ProteinsasymmetryE266QEpsilon lineageNsp15nsSNPSARS‐CoV‐2space groupX‐ray crystallography

Identifiers

PMID40411374
PMCPMC12102731

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.